blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1623229

EP1623229 - SELECTION OF B CELLS WITH SPECIFICITY OF INTEREST: METHOD OF PREPARATION AND USE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.10.2014
Database last updated on 06.07.2024
Most recent event   Tooltip10.10.2014Application deemed to be withdrawnpublished on 12.11.2014  [2014/46]
Applicant(s)For all designated states
Elatos GmbH
Campus-Vienna-Biocenter 3
1030 Wien / AT
[2013/26]
Former [2011/09]For all designated states
Intercell AG
Campus Vienna Biocenter 3
1030 Vienna / AT
Former [2006/06]For all designated states
Cytos Biotechnology AG
Wagistrasse 25
8952 Zürich-Schlieren / CH
Inventor(s)01 / BACHMANN, Martin, F.
Goldackerweg 8
CH-8472 Seuzach / CH
02 / GATTO, Dominique
Im Struppen 14
CH-8048 Zürich / CH
 [2006/06]
Representative(s)Bösl, Raphael Konrad, et al
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2010/38]Bösl, Raphael Konrad, et al
Isenbruck Bösl Hörschler Wichmann LLP Patentanwälte Prinzregentenstrasse 68
81675 München / DE
Former [2006/06]Sperrle, Martin
Cytos Biotechnology AG, Wagistrasse 25
8952 Schlieren / CH
Application number, filing date04732971.914.05.2004
[2006/06]
WO2004EP05208
Priority number, dateUS20030470443P15.05.2003         Original published format: US 470443 P
[2006/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004102198
Date:25.11.2004
Language:EN
[2004/48]
Type: A2 Application without search report 
No.:EP1623229
Date:08.02.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 25.11.2004 takes the place of the publication of the European patent application.
[2006/06]
Search report(s)International search report - published on:EP27.01.2005
ClassificationIPC:G01N33/566, G01N33/569, G01N33/50, C07K16/00
[2006/06]
CPC:
G01N33/56972 (EP,US); G01N33/5052 (EP,US); G01N33/54313 (EP,US);
G01N33/58 (EP,US); G01N27/447 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/06]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:SELEKTION VON B-ZELLEN MIT GEWÜNSCHTER SPEZIFITÄT: VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG[2006/06]
English:SELECTION OF B CELLS WITH SPECIFICITY OF INTEREST: METHOD OF PREPARATION AND USE[2006/06]
French:SELECTION DES LYMPHOCYTES B AVEC SPECIFICITE D'INTERET : PROCEDE DE PREPARATION ET UTILISATION[2006/06]
Entry into regional phase22.11.2005National basic fee paid 
22.11.2005Designation fee(s) paid 
22.11.2005Examination fee paid 
Examination procedure22.11.2005Amendment by applicant (claims and/or description)
22.11.2005Examination requested  [2006/06]
12.12.2011Despatch of a communication from the examining division (Time limit: M06)
22.06.2012Reply to a communication from the examining division
11.11.2013Despatch of a communication from the examining division (Time limit: M06)
22.05.2014Application deemed to be withdrawn, date of legal effect  [2014/46]
17.06.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/46]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.12.2011
Fees paidRenewal fee
30.03.2006Renewal fee patent year 03
14.05.2007Renewal fee patent year 04
13.03.2008Renewal fee patent year 05
25.05.2009Renewal fee patent year 06
31.03.2010Renewal fee patent year 07
24.05.2011Renewal fee patent year 08
23.03.2012Renewal fee patent year 09
27.05.2013Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.05.201411   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US5326696  (CHANG TSE W [US]) [Y] 5,7-11,37-42,44-46,49,51-57,59,60 * column A * * column 4, line 58 - column 6, line 15 * * column 9, lines 38-60 * * column 12, lines 30-66 *;
 [A]WO03024481  (CYTOS BIOTECHNOLOGY AG [CH], et al) [A] 1,2,10-46,54-62 * abstract * * page 6, paragraph 1 * * page 26, paragraph 4 - page 28, paragraph 4 * * page 36, paragraph 3 - page 38, paragraph 2 * * page 39, paragraph 2 - page 50, paragraph 1 *;
 [XY]  - WEITKAMP JORN-HENDRIK ET AL, "Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles.", JOURNAL OF IMMUNOLOGICAL METHODS, (20030401), vol. 275, no. 1-2, ISSN 0022-1759, pages 223 - 237, XP004416763 [X] 1,2,12-36,43,58,61,62 * abstract * * page 224, column 2, paragraph 2 - page 225, column 2, paragraph 2; figure 1 * * page 226, column 1, paragraphs 1,2 * * page 226, column 2, paragraph 3 - page 227, column 2, paragraph 2 * * page 235, column 1, paragraph 3 - page 236, column 1, paragraph 2 * [Y] 5,7-11,37-42,44-46,49,51-57,59,60

DOI:   http://dx.doi.org/10.1016/S0022-1759(03)00013-9
 [Y]  - FEHR T ET AL, "T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (19980804), vol. 95, no. 16, ISSN 0027-8424, pages 9477 - 9481, XP002212229 [Y] 5,7-11,37-42,44-46,49,51-57,59,60 * abstract * * page 9477, column 2, paragraphs 1,2 * * page 9480, column 2, paragraphs 1,2 *

DOI:   http://dx.doi.org/10.1073/pnas.95.16.9477
 [Y]  - VASILJEVA I ET AL, "Mosaic Qbeta coats as a new presentation model", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19980710), vol. 431, no. 1, ISSN 0014-5793, pages 7 - 11, XP004258931 [Y] 5,7-11,37-42,44-46,49,51-57,59,60 * abstract * * page 7, column 1, paragraph 1 - column 2, paragraph 1 * * page 10, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0014-5793(98)00716-9
 [Y]  - JEGERLEHNER A ET AL, "A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20020819), vol. 20, no. 25-26, ISSN 0264-410X, pages 3104 - 3112, XP004374549 [Y] 5,7-11,37-42,44-46,49,51-57,59,60 * abstract * * page 3104, column 2, paragraph 2 - page 3105, column 1, paragraph 1 * * page 3111, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0264-410X(02)00266-9
 [Y]  - BACHMANN M F ET AL, "The influence of virus structure on antibody responses and virus serotype formation", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (19961201), vol. 17, no. 12, ISSN 0167-5699, pages 553 - 558, XP004071007 [Y] 5,7-11,37-42,44-46,49,51-57,59,60 * abstract * * page 553, column 1, paragraph 1 - column 2, paragraph 1 * * page 557, column 2, paragraph 5 *

DOI:   http://dx.doi.org/10.1016/S0167-5699(96)10066-9
 [A]  - BENHAR I, "Biotechnological applications of phage and cell display", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, (20010201), vol. 19, no. 1, ISSN 0734-9750, pages 1 - 33, XP004231501 [A] 1,2,5,7-46,49,51-62 * abstract * * page 21, paragraph 2 - page 23, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0734-9750(00)00054-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.